A Phase IV, Open-Label, Randomized, Active-controlled, Single-Center Study of ZYNRELEF ® for Postoperative Analgesia After Laparoscopic Sleeve Gastrectomy

Conditions:   Post Operative Pain, Acute;   Bariatric Surgery Candidate;   Postoperative Pain;   Postoperative Opioid Use in Bariatric Surgery Intervention:   Drug: ZYNRELEF 200Mg-6Mg Extended-Release Solution Sponsors:   Dr. Yannis Raftopoulos;   Heron Therapeutics Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials